Humana Inc. $HUM Shares Sold by Bank of Nova Scotia

Bank of Nova Scotia cut its stake in Humana Inc. (NYSE:HUM) by 68.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 77,288 shares of the insurance provider’s stock after selling 165,097 shares during the period. Bank of Nova Scotia’s holdings in Humana were worth $20,108,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Illinois Municipal Retirement Fund grew its position in shares of Humana by 9.6% during the third quarter. Illinois Municipal Retirement Fund now owns 49,658 shares of the insurance provider’s stock worth $12,920,000 after buying an additional 4,351 shares in the last quarter. Bank of New York Mellon Corp raised its holdings in Humana by 161.5% in the third quarter. Bank of New York Mellon Corp now owns 1,717,767 shares of the insurance provider’s stock valued at $446,911,000 after acquiring an additional 1,060,767 shares in the last quarter. National Pension Service lifted its stake in Humana by 2.8% in the third quarter. National Pension Service now owns 189,601 shares of the insurance provider’s stock worth $49,328,000 after acquiring an additional 5,150 shares during the last quarter. Tejara Capital Ltd acquired a new position in Humana during the 3rd quarter worth approximately $1,873,000. Finally, AMG National Trust Bank grew its holdings in Humana by 106.5% during the 3rd quarter. AMG National Trust Bank now owns 16,953 shares of the insurance provider’s stock worth $4,411,000 after acquiring an additional 8,744 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on HUM. TD Cowen reduced their price objective on shares of Humana from $260.00 to $173.00 and set a “hold” rating on the stock in a report on Friday, February 13th. Truist Financial lowered their target price on shares of Humana from $285.00 to $200.00 and set a “hold” rating for the company in a research note on Tuesday, February 17th. The Goldman Sachs Group dropped their target price on Humana from $215.00 to $158.00 and set a “sell” rating on the stock in a report on Friday, February 13th. Wolfe Research raised their price target on Humana from $300.00 to $325.00 and gave the company an “outperform” rating in a research note on Thursday, January 8th. Finally, UBS Group reaffirmed a “neutral” rating on shares of Humana in a report on Wednesday, February 25th. Seven analysts have rated the stock with a Buy rating, sixteen have issued a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $225.48.

Insider Activity at Humana

In other news, insider Sanjay K. Shetty bought 810 shares of Humana stock in a transaction dated Monday, February 23rd. The stock was acquired at an average cost of $185.21 per share, with a total value of $150,020.10. Following the acquisition, the insider owned 11,657 shares of the company’s stock, valued at approximately $2,158,992.97. This trade represents a 7.47% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.20% of the company’s stock.

Humana Stock Up 2.9%

Shares of NYSE:HUM opened at $170.18 on Tuesday. The firm has a 50 day simple moving average of $210.78 and a 200-day simple moving average of $246.62. Humana Inc. has a twelve month low of $163.60 and a twelve month high of $315.35. The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.70. The company has a market capitalization of $20.43 billion, a PE ratio of 17.33, a P/E/G ratio of 1.77 and a beta of 0.44.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) EPS for the quarter, beating analysts’ consensus estimates of ($4.01) by $0.05. Humana had a net margin of 0.92% and a return on equity of 11.43%. The firm had revenue of $32.64 billion for the quarter, compared to the consensus estimate of $32.08 billion. During the same period last year, the firm posted ($2.16) EPS. The company’s revenue was up 11.3% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, equities analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, March 27th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 2.1%. Humana’s payout ratio is 36.05%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.